Gammagard Liquid 10%: Completed Phase III enrollment

Baxter completed enrollment of 390 AD patients ages 50-89 in a double-blind, placebo-controlled, U.S.

Read the full 140 word article

How to gain access

Continue reading with a
two-week free trial.